DE3169848D1 - Herpes simplex type i fraction vaccine and process for its preparation - Google Patents

Herpes simplex type i fraction vaccine and process for its preparation

Info

Publication number
DE3169848D1
DE3169848D1 DE8181401407T DE3169848T DE3169848D1 DE 3169848 D1 DE3169848 D1 DE 3169848D1 DE 8181401407 T DE8181401407 T DE 8181401407T DE 3169848 T DE3169848 T DE 3169848T DE 3169848 D1 DE3169848 D1 DE 3169848D1
Authority
DE
Germany
Prior art keywords
herpes simplex
preparation
simplex type
vaccine
fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8181401407T
Other languages
English (en)
Inventor
Alexander U Bertland
George P Lampson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE3169848D1 publication Critical patent/DE3169848D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE8181401407T 1980-09-11 1981-09-10 Herpes simplex type i fraction vaccine and process for its preparation Expired DE3169848D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/186,365 US4317811A (en) 1980-09-11 1980-09-11 Herpes simplex type 1 subunit vaccine

Publications (1)

Publication Number Publication Date
DE3169848D1 true DE3169848D1 (en) 1985-05-15

Family

ID=22684654

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8181401407T Expired DE3169848D1 (en) 1980-09-11 1981-09-10 Herpes simplex type i fraction vaccine and process for its preparation

Country Status (10)

Country Link
US (1) US4317811A (de)
EP (1) EP0048201B1 (de)
JP (1) JPS5780326A (de)
AT (1) ATE12583T1 (de)
CA (1) CA1174599A (de)
DE (1) DE3169848D1 (de)
DK (1) DK401981A (de)
FI (1) FI73596C (de)
IE (1) IE51553B1 (de)
NO (1) NO813087L (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4388035A (en) * 1979-08-01 1983-06-14 Bud Antle, Inc. Dibble tube soil plug planter
US4540669A (en) * 1980-09-11 1985-09-10 Merck & Co., Inc. Herpes simplex type I subunit vaccine
US4554159A (en) * 1981-11-12 1985-11-19 Institute Merieux Vaccine and method of immunizing against herpes simplex virus (types 1 and 2)
CA1201987A (en) * 1982-03-24 1986-03-18 Gordon R.B. Skinner Vaccine against dna viruses
EP0089854B1 (de) * 1982-03-24 1988-12-07 The University Of Birmingham DNS Viren-Vakzin
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
JPS6051120A (ja) * 1983-08-31 1985-03-22 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニットワクチン
US4618578A (en) * 1984-07-17 1986-10-21 Chiron Corporation Expression of glycoprotein D of herpes simplex virus
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
US5244792A (en) * 1984-04-06 1993-09-14 Chiron Corporation Expression of recombinant glyoprotein B from herpes simplex virus
US5612041A (en) * 1984-07-17 1997-03-18 Chiron Corporation Recombinant herpes simplex gD vaccine
JPS6153226A (ja) * 1984-08-24 1986-03-17 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニツトワクチンの精製方法
US4761470A (en) * 1985-12-16 1988-08-02 Merck & Co., Inc. Immunogenic synthetic peptide capable of eliciting herpes simplex virus neutralizing antibody
US5955088A (en) * 1992-02-03 1999-09-21 Cedars-Sinai Medical Center Pharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteins
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
CA2307832C (en) * 1997-10-31 2005-09-06 Merck & Co., Inc. A method of improved mixing of a varicella-infected cell culture in roller bottles
AU2002249895A1 (en) * 2001-01-05 2002-07-16 Joslin Diabetes Center, Inc. Autoantigen composition
WO2007127787A2 (en) * 2006-04-25 2007-11-08 Joslin Diabetes Center, Inc. Insulin autoantigen-specific regulatory cd4+ t cells
RU2552341C1 (ru) * 2014-02-26 2015-06-10 Федеральное государственное унитарное предприятие "Санкт-Петербургский научно-исследовательский институт вакцин и сывороток и предприятие по производству бактерийных препаратов" Федерального медико-биологического агентства (ФГУП СПбНИИВС ФМБА России) Фармацевтическая композиция для получения антигерпетической поливакцины и лекарственной формы на ее основе

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI66020C (fi) * 1977-09-19 1984-08-10 Merck & Co Inc Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2

Also Published As

Publication number Publication date
EP0048201B1 (de) 1985-04-10
DK401981A (da) 1982-03-12
IE51553B1 (en) 1987-01-07
FI812704L (fi) 1982-03-12
CA1174599A (en) 1984-09-18
EP0048201A2 (de) 1982-03-24
NO813087L (no) 1982-03-12
IE812096L (en) 1982-03-11
FI73596C (fi) 1987-11-09
ATE12583T1 (de) 1985-04-15
JPS5780326A (en) 1982-05-19
EP0048201A3 (en) 1982-09-15
US4317811A (en) 1982-03-02
FI73596B (fi) 1987-07-31

Similar Documents

Publication Publication Date Title
DE3169848D1 (en) Herpes simplex type i fraction vaccine and process for its preparation
DE3176404D1 (en) Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine
PH25689A (en) Materials, methods for herpes simplex virus vaccination
GB2079786B (en) Production of viral antigens
NO153692C (no) Fremgangsmaate ved fremstilling av en antigen, immunogen subenhet av herpes simplex type 1 (hsv1) eller type 2 subenhet (hsv2).
JPS56102786A (en) Preparation of concentrated virus group
EP0101348A3 (de) Impfstoff gegen Geflügelproventriculitis, Geflügelproventriculitisreovirus, Verfahren zur Herstellung des Impfstoffes und Verfahren zum Schutz des Geflügels gegen Proventriculitis
IT1094413B (it) Procedimento per la preparazione di un ceppo virale di gastroenterite trasmissibile attenuato da applicare a vaccini vivi
ZA813479B (en) Process for the isolation of viral glycoproteic antigens and its application to the preparation of vaccines
ES467557A1 (es) Un procedimiento para la preparacion de una nueva vacuna queprotege a las aves ponedoras de huevos contra la enfermedad del descenso de la produccion de huevos.
JPS5527178A (en) Live influenza virus vaccine
LU78951A1 (fr) Nouveau vaccin
GB1486186A (en) Vaccines against feline leukaemia and the group of diseases associated with feline leukaemis/virus infection
PT70556A (en) Vaccines against diseases caused by reo-virus and process for the preparation of those vaccines
JPS5781415A (en) Single strain vaccine for infectious disease by some strains of cilia bacteria
YU42204B (en) Process for preparing vaccines against the virus of early summer meningoencephalitis
GB1466633A (en) Method for immunizing nursing piglets against transmissible gastroenteritis -tge- virus
GB1358321A (en) Method od tissue cell culture
ZA796944B (en) Vaccines against diseases,caused by reovirus,and process for the preparation of those vaccines
PT69953A (en) Process for preparing a composition comprising a lyophilized herpes virus
CA973475A (en) Culture of a high titre strain of turkey herpes virus and method for preparation thereof suitable for the production of marek's disease vaccine
ES471766A1 (es) Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza
JPS57167925A (en) Preparation of mixed vaccine for domestic fowl
JPS54132226A (en) Raw virus vaccine for poutly infecting laryngth bronchus imflammatory
SU1499917A1 (ru) Штамм goosa parvovirus для приготовления вакцинных препаратов против вирусного энтерита гусей

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee